glp-1 drugs differences Drug Comparison in Diabetes and Obesity Treatment Comparison of GLP-1 medications for
Description
doi: 10.2337/cd23-0023
After screening and full-text review, 9 studies met the inclusion criteria for synthesis
Two pharmacoepidemiological analyses using electronic health records have reported that use of GLP-1R agonists is associated with lower rates of opioid overdose
DO use only FDA-approved medications
Abstract Aims/hypothesis We compared the effects of sodiumglucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on renal outcomes in individuals with type 2 diabetes, focusing on the changes in eGFR and albuminuria
[DOI] [PubMed] [Google Scholar] 575.Fridolf T., Bottcher G., Sundler F., Ahren B
